ARCUHYA
DEAD

Serial Number

79185574

Owner

NOVARTIS AG

Filing Date

Jan 22, 2016

Add to watchlist:

No watchlists yet
View on USPTO

ARCUHYA Trademark

Serial Number: 79185574

ARCUHYA is a trademark filed by NOVARTIS AG on January 22, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

January 22, 2016

Registration Date

Not Registered

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

IRREGULARITY FROM IB EXAMINED BY MPU
Jan 9, 2018 IRRH
IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
Dec 11, 2017 IRFI
FINAL DISPOSITION NOTICE SENT TO IB
Dec 5, 2017 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 5, 2017 FICR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 30, 2017 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 30, 2017 OPNR
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Jan 13, 2017 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jan 12, 2017 DETH
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 5, 2016 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 5, 2016 ABN2
REFUSAL PROCESSED BY IB
May 27, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 9, 2016 RFCS
REFUSAL PROCESSED BY MPU
May 9, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 7, 2016 RFCR
NON-FINAL ACTION WRITTEN
May 6, 2016 CNRT
ASSIGNED TO EXAMINER
May 4, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 8, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 4, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 1, 2016 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 31, 2016 REPR